Trump Signs Memo to Increase Transparency in Pharmaceutical TV Drug Ads

President Trump on Tuesday signed an executive memorandum directing the Department of Health and Human Services (HHS) to make prescription drug advertising more transparent and accurate.

The Details: The memorandum tasks HHS Secretary Robert F. Kennedy Jr. with “ensuring transparency” and providing “accurate” information about drug risks, while the Food and Drug Administration (FDA) Commissioner is directed to enforce existing laws that make sure ads are not “misleading”, including by increasing disclosure of potential side effects. The FDA said it sent out roughly 100 cease-and-desist letters, and thousands of letters warning pharmaceutical companies to remove “misleading ads.” The action would remove a 1997 policy change by the FDA that allows pharmaceutical companies to use a "major-risk statement" in their ads and direct viewers to a website, toll-free number, or print insert for more detailed information. 

Key Quotes: In a statement, Kennedy said, “Pharmaceutical ads hooked this country on prescription drugs. We will shut down that pipeline of deception and require drug companies to disclose all critical safety facts in their advertising.”

For Context: The US and New Zealand are the only two countries in the world that allow direct-to-consumer (DTC) advertising. Kennedy has been a vocal critic of DTC pharmaceutical advertising, and expressed concern about what he calls the overmedicalization of American children. Until 1997, pharmaceutical companies were required to disclose full contraindications, boxed warnings, and common precautions in DTC prescription drug ads. 

How the Media Covered It: Fox News (Right bias) interviewed Fox News senior medical analyst Dr. Marc Siegel, who said Kennedy makes a strong case for wanting to remove DTC ads, citing past evidence that doctors are more likely to prescribe certain drugs after visits from pharmaceutical representatives. Siegel also argued that consumers’ ability to look symptoms up online and through AI is more effective than pharma ads. Politico (Lean Left) and The Hollywood Reporter (Lean Left) emphasized the impact on pharmaceutical companies and pharma ad dollars. Politico wrote, “More stringent advertising rules could make it more difficult for drugmakers to market their medicines.” It also mentioned previous bipartisan calls for the FDA to take enforcement action against pharma social media ads. The Hollywood Reporter said "some of the biggest media and entertainment companies might feel the pain," and quoted a media executive who said the regulations would make drug commercials longer. 

Written by the AllSides staff (of humans). Learn more. Support our mission.